DHU-21323-10034
5 vaccinations
7 coded responses
61 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 981 / WA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Pfizer-BioNTech
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-11
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body achesAdult check-in
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Myalgia — Feeling: Fair · Headache, Joint pains, Muscle or body aches · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Elbow pain for several days with adjacent muscle pain. On side where injection was received.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-05
Survey response — day 7, dose 2MedDRA: Arthralgia, Lymphadenopathy — Feeling: Fair · Joint painsFree text: Elbow pain on same side as injection. My doctor thinks it might be a swollen lymph node.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
- 2021-02-19
- 2021-02-26
-
2021-03-05
Survey response — day 35, dose 2MedDRA: Labyrinthitis, Ophthalmic migraine, Vertigo — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Vertigo. Diagnosed as labyrinthitis. Also experienced an ocular migraine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Report sent to call center — day 35, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-12
-
2021-04-30
Survey response — 3 months, dose 2MedDRA: Office visit, Retinal vasculitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Retinal vasculitis diagnosed 3 days ago. Retinal venous sheathing. I had symptoms of flashes and floaters and during dilated fundus exam, they discovered the vasculitis. No other symptoms. Referred for further evaluation to medical retina specialistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-15
-
2021-06-17
Call successfulParticipant prefers to complete VAERS report online
-
2021-06-17
Call successfulParticipant prefers to complete VAERS report online
-
2021-06-17
Call successfulParticipant prefers to complete VAERS report online
- 2021-07-30
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-16
- 2021-10-21
- 2021-10-31
- 2021-11-04
-
2021-11-11
Survey response — day 42, dose 3MedDRA: Migraine with aura — Feeling: FairFree text: Migraine aura todayMedDRA releases: 2024-11 · check-in free text available
- 2021-12-30
- 2022-03-31
-
2022-04-29
Dose 4 — Moderna
- 2022-05-01
- 2022-05-02
- 2022-05-03
- 2022-05-04
- 2022-05-05
- 2022-05-06
- 2022-05-15
- 2022-05-20
- 2022-05-27
- 2022-06-03
- 2022-06-10
- 2022-07-29
-
2022-10-03
Dose 5 — Moderna
-
2022-10-04
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-17
- 2022-10-25
-
2022-10-31
Survey response — day 28, dose 5MedDRA: Nasal congestion, Nasopharyngitis, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold symptoms Sore throat, nasal congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Report sent to call center — day 28, dose 5Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-07
- 2022-11-14
-
2023-01-02
Survey response — 3 months, dose 5MedDRA: Nasopharyngitis, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-04-29 | Moderna | No |
| 5 | 2022-10-03 | Moderna | No |
Call center
4 call center cases
4 successful
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Elbow pain for several days with adjacent muscle pain. On side where injection was received.
Release 3 — day 7, dose 2
Systemic reaction (other): Elbow pain on same side as injection. My doctor thinks it might be a swollen lymph node.
Release 5 — day 35, dose 2
Symptoms: Vertigo. Diagnosed as labyrinthitis. Also experienced an ocular migraine.
Release 8 — 3 months, dose 2
Symptoms: Retinal vasculitis diagnosed 3 days ago. Retinal venous sheathing. I had symptoms of flashes and floaters and during dilated fundus exam, they discovered the vasculitis. No other symptoms. Referred for further evaluation to medical retina specialist cut off by CDC
Release 10 — day 42, dose 3
Symptoms: Migraine aura today
Release 12 — day 28, dose 5
Symptoms: Cold symptoms Sore throat, nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Labyrinthitis | ✓ | ✓ | ✓ |
| SD | Migraine with aura | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SD | Ophthalmic migraine | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Retinal vasculitis | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release